Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010

Pharmacoepidemiology and Drug Safety

Volumn 20, Issue 12, 2011, Pages 1269-1277

  Fischer, Benedikt ^a,b   Jones, Wayne ^a   Krahn, Murray ^c,d   Rehm, Jürgen ^b,e  

^a SIMON FRASER UNIVERSITY   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Canada; Health system; Pain care; Prescription monitoring; Prescription opioid analgesics; Psychoactive drug use; Public health

Indexed keywords

CODEINE; FENTANYL; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; OPIATE; OXYCODONE; PETHIDINE;

ARTICLE; CANADA; DRUG SURVEILLANCE PROGRAM; DRUG USE; HUMAN; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS;

ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; CANADA; COMMUNITY PHARMACY SERVICES; DRUG UTILIZATION; HUMANS; PAIN; PHYSICIAN'S PRACTICE PATTERNS; POISSON DISTRIBUTION; REGRESSION ANALYSIS; TIME FACTORS;

EID: 81955168046     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2190     Document Type: Article

References (49)

1. International Narcotics Control Board. Narcotic Drugs: Estimated World Requirements for 2011- Statistics for 2009. E/INCB/2009/1. International Narcotics Control Board: Vienna, Austria, 2010.
2. Fischer B, Gittins J, Rehm J. Characterizing the 'awakening elephant': prescription opioid misuse in North America: Epidemiology, harms, interventions. Contemp Drug Probl 2008; 35: 397-426.
3. Joranson DE, Gilson A. Wanted: a public health approach to prescription opioid abuse and diversion. Pharmacoepidemiol Drug Saf 2006; 15: 632-634.
4. Manchikanti L. National Drug Control Policy and Prescription Drug Abuse: Facts and Fallacies. Pain Physician 2007; 10: 399-424.
5. Hurwitz W. The challenge of prescription drug misuse: A review and commentary. Pain Med 2005; 6: 152-161.
6. Warner M, Chen LH, Makuc DM. NCHS data brief: Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006 (vol. 22). Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics: Hyattsville, MD, U.S., 2009.
7. Paulozzi L, Budnitz D, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006; 15: 618-627.
8. Health Canada. Canadian Alcohol and Drug Use Monitoring Survey (CADUMS): Summary Results for 2008. [3 February 2010]. Health Canada: Ottawa, ON, 2009.
9. Fischer B, Nakamura N, Iaolomiteanu A, Boak A, Rehm J. Assessing the prevalence of non-medical prescription opioid use in the general Canadian population: Methodological issues and questions. Can J Psychiat 2010; 55: 606-609.
10. Paglia-Boak A, Mann RE, Adlaf EM, Rehm J. Detailed OSDUHS Findings - Drug Use 1977-2009 Among Ontario Students. CAMH Research Document Series, 27. Centre for Addiction and Mental Health (CAMH): Toronto, ON, 2009.
11. Poulin C, Elliot D. Student Drug Use Survey in the Atlantic Provinces 2007: Atlantic Technical Report. C2007-906454-X. Dalhousie University, Community Health and Epidemiology: Halifax, NS, 2007.
12. Fischer B, Nakamura N, Rush B, Rehm J, Urbanoski K. Changes in and characteristics of admissions to substance use treatment related to problematic prescription opioid use in Ontario, 2004-2009. Drug Alcohol Depend 2010; 109: 257-260.
13. Dhalla I, Mamdani M, Sivilotti M, Kopp A, Qureshi O, Juurlink D. Opioid analgesic prescribing and mortality before and after the introduction of long-acting oxycodone in Ontario. CMAJ 2009; 181: 891-896.
14. Fischer B, Rehm J, Goldman B, Popova S. Non-medical Use of Prescription Opioids and Public Health in Canada. Can J Public Health 2008; 99: 182-184.
15. Gardner-Nix J. Principles of opioid use in chronic noncancer pain. CMAJ 2003; 169: 38-43.
16. Fishman SM, Papazian JS, Gonzalez S, Riches PS, Gilson A. Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain. Pain Med 2004; 5: 309-324.
17. Brushwood D. Maximizing the value of electronic prescription monitoring programs. J Law Med Ethics 2003; 31: 41-54.
18. Webster BS, Cifuentes M, Verma S, Pransky G. Geographic Variation in Opioid Prescribing for Acute, Work-Related, Low Back Pain and Associated Factors: A Multilevel Analysis. Am J Ind Med 2009; 52: 162-171.
19. Fishman SM. Commentary in response to Paulozzi et al: prescription drug abuse and safe pain management. Pharmacoepidemiol Drug Saf 2006; 15: 628-631.
20. Brennan F, Carr DB, Cousins M. Pain Management: A Fundamental Human Right. Anesth Analg 2007; 105: 205-221.
21. Morgan S, Raymond C, Mooney D, Martin D. The Canadian Rx Atlas: 2nd Edition. RA410.55.C35C36 2008. BC, University of British Columbia Centre for Health Services and Policy Research: Vancouver, 2008.
22. Silversides A. Ontario takes aim at painkiller abuse. CMAJ 2009; 181: E141-E142.
23. Boulanger A, Clark AJ, Squire P, Cui E, Horbay GLA. Chronic pain in Canada: Have we improved our management of chronic noncancer pain? Pain Res Manag 2007; 12: 39-47.
24. El-Aneed A, Alaghehbandan R, Gladney N, Collins K, MacDonald D, Fischer B. Prescription drug abuse and methods of diversion: The potential role of a pharmacy network. J Subst Use 2009; 14: 75-83.
25. IMS Brogan, a unit of IMS. [serial online]. IMS Brogan, 2010.
26. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2010. [serial online]. Norwegian Institute of Public Health, 2009.
27. WHO Collaborating Centre for Drug Statistics Methodology. Definition and general considerations. [serial online]. Norwegian Institute of Public Health, 2009.
28. World Health Organization (WHO). WHO's pain ladder. [serial online]. World Health Organization, 2010.
29. Statistics Canada. Canadian Community Health Survey (CCHS) - Cycle 1.1. [serial online]. Statistics Canada, 2010.
30. Skrondal A, Rabe-Hesketh SE. Generalized Latent Variable Modeling. Chapman and Hall/ CRC: Washington DC, 2004.
31. Box G, Hunter S, Hunter WG. Statistics for Experimenters: Design, Innovation, and Discovery (2nd edn). Wiley: Hoboken, NJ, 2005.
32. StataCorp LP. Stata 11. [serial online]. Stata Corporation LP, 2010.
33. van den Kerkhof EG, Hopman WG, Towheed TE, Anastassiades TP, Goldstein DH. The impact of sampling and measurement on the prevalence of self-reported pain in Canada. Pain Res Manag 2003; 8: 157-163.
34. Birse TM, Lander J. Prevalence of Chronic Pain. Can J Public Health 1998; 89: 129-131.
35. Passik SD, Weinreb HJ. Managing chronic nonmalignant pain: Overcoming obstacles to the use of opioids. Adv Ther 2000; 17: 70-83.
36. Jovey RD, Ennis J, Gardner-Nix J et al. Use of opioid analgesics for the treatment of chronic noncancer pain - A consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 2003; 8: 3A-14A.
37. Sketris IS, Langille-Ingram EM, Lummis HL. Strategic Opportunities for Effective Optimal Prescribing and Medication Management. Can J Clin Pharmacol 2009; 16: e103-e125.
38. Samoy LJ, Zed PJ, Wilbur K, Balen RM, Abu-Laban RB, Roberts M. Drug-Related Hospitalizations in a Tertiary Care Internal Medicine Service of a Canadian Hospital: A Prospective Study. Pharmacotherapy 2006; 26: 1578-1586.
39. Motov SM, Khan ANGA. Problems and barriers of pain management in the emergency department: Are we ever going to get better? J Pain Res 2009; 2: 5-11.
40. Fischer B, Rehm J. Deaths related to the use of prescription opioids. CMAJ 2009; 181: 881-882.
41. Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med 2010; 363: 1981-1985.
42. Isaac P, Seto W, Lanctot KL. Use and abuse of prescription opioids in Canada 1978 to1989. Can J Clin Pharmacol 1995; 2: 81-86.
43. Gilson A, Ryan K, Joranson DE, Dahl J. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control. J Pain Symptom Manage 2004; 28: 176-188.
44. Baehren DF, Marco CA, Droz DE, Sinha S, Callan EM, Akpunonu P. A Statewide Prescription Monitoring Program Affects Emergency Department Prescribing Behaviors. Ann Emerg Med 2010; 56: 19-23.
45. Barrett K, Watson A. Physician Perspectives on a Pilot Prescription Monitoring Program. J Pain Palliat Care Pharmacother 2005; 19: 5-13.
46. Morley-Foster PK, Clark AJ, Speechley M, Moulin DE. Attitudes toward opioid use for chronic pain: a Canadian physician survey. Pain Res Manag 2003; 8: 187-188.
47. Joranson D, Carrow G, Ryan K et al. Pain management and prescription monitoring. J Pain Symptom Manage 2002; 23: 231-238.
48. Pain & Policy Studies Group. Achieving Balance in Federal and State Pain Policy: A Guide to Evaluation (5th edn). University of Wisconsin Paul P. Carbone Comprehensive Cancer Center: Madison, WI, 2008.
49. Sadowski CA, Carrie AG, Grymonpre RE, Metge CJ, St John P. Access and intensity of use of prescription analgesics among older Manitobans. Can J Clin Pharmacol 2009; 16: e322-e330.